Obesity Market Research Reports & Industry Analysis
Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come.
The definitions or measurement characteristics for overweight and obesity have varied over time. The varied definitions affect prevalence statistics and make it difficult to compare data from different studies. The prevalence of overweight and obesity is commonly assessed by using body mass index (BMI). A BMI over 25 kg/m2 is defined as overweight, and a BMI of over 30 kg/m2 as obese. These markers provide the common benchmarks for assessment, but the risks of disease in all populations can increase progressively from lower BMI levels.
According to the World Health Organization, adult mean BMI levels of 22-23 kg.m2 are found in Africa and Asia, while levels of 25-27 kg.m2 are prevalent across North America, Europe, and in some Latin American, North African and Pacific Island countries. BMI increases among middle-aged elderly people, who are at the greatest risk of health complications. In countries undergoing nutrition transition, overnutrition often coexists with undernutrition. People with a BMI below 18.5 kg/m2 tend to be underweight.
Obesity Industry Research & Market Reports
-
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-Like Peptide-1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase) - Global Forecast to 2030
... age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role ... Read More
-
Non-Invasive Fat Reduction Technologies
... 2030, growing at a CAGR of 15.8% over the analysis period 2024-2030. Cryolipolysis Technology, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$2.5 Billion by the ... Read More
-
Anti-Obesity Drugs
... CAGR of 8.7% over the analysis period 2024-2030. Prescription Drugs, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$4.9 Billion by the end of the analysis ... Read More
-
Anti-Obesity Drugs Market by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Tirzepatide, Semaglutide, Retatrutide, Survodutide, Cagrilintide and Semaglutide, Orforglipron, Liraglutide and Other Active Compounds), Mechanism of Action (GLP-1 Agonist / GIP Agonist, GLP-1 Agonist / GCGR Agonist, GLP-1 Agonist, GLP-1 Agonist / Amylin Analogue, GLP-1 / GCGR / GIP Agonist and Other Mechanisms of Action), Type of Agonist (Single-Agonist, Dual-Agonist and Tri-Agonist), Action Pathway (Centrally Acting, Peripherally Acting and Centrally Acting, and Peripherally Acting), Route of Administration (Oral and Parenteral), Geographical Regions (North America, Europe, Asia-Pacific and Latin America), Sales Forecast and Key Players: Industry Trends and Global Forecasts, till 2035
... CAGR of 21. 1% during the forecast period, till 2035. The opportunity for anti-obesity drugs market has been distributed across the following segments: Type of Molecule Biologics Small Molecules Active Compound Used Tirzepatide Semaglutide Retatrutide ... Read More
-
Anti-obesity Drugs Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... safety profiles for managing weight. Ongoing research and advancements in understanding the biological mechanisms of obesity are driving the development of more targeted and effective anti-obesity drugs. Furthermore, innovations in genomics and biotechnology are facilitating ... Read More
-
Anti-Obesity Medication Market Size, Share, By Drug Type, Mechanism of Action, Distribution Channel, and Region - Trends, Analysis and Forecast till 2035
... with being overweight. In addition, rising R&D activities for development of anti-obesity drugs, and increasing investment in R&D sectors are another factors propelling growth of the global market. Anti-Obesity Medication Market Report Highlights: The anti-obesity ... Read More
-
Supplements in the Ozempic Age
... are adapting. The Supplements in the Ozempic Age report delivers comprehensive market data, consumer insights, and strategic opportunities to help your business thrive in this dramatically-shifting environment. What’s Inside? Market Sizing & Growth Analysis: Get ... Read More
-
United States Bariatric Surgery Devices Market: Market Size, Forecast, Insights, and Competitive Landscape
... United States bariatric surgery devices market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States bariatric surgery ... Read More
-
Bariatric Surgery Devices – A Global Market Overview
... disorders. It reduces stomach size, modifies gut hormone levels that regulate hunger and fullness, or limiting nutrient absorption. Sleeve gastrectomy, Roux-en-Y Gastric Bypass (RYGB), One Anastomosis Gastric Bypass (OAGB), Non-Invasive Bariatric Surgery, and Biliopancreatic Diversion ... Read More
-
Bariatric Surgery Devices Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... during 2025-2034. This report on global bariatric surgery market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global ... Read More
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... projected to to expand to a value of USD 3.02 billion in 2030 from USD 1.40 billion in 2024, with a significant CAGR of 13.6%. The autoinjector finished formulations market is projected to surge to ... Read More
-
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030
... global injection pen market is projected to reach USD 74.1 billion by 2030 from USD 47.0 billion in 2024, at a CAGR of 7.9% during the forecast period. The rapid growth in the geriatric population ... Read More
-
Eating Disorder Clinics in the US - Industry Market Research Report
... to meet the need. However, most individuals suffering from an eating disorder do not receive treatment because of the high costs, lack of information about or stigma associated with treatment. Many public and private health ... Read More
-
Lifestyle Diseases Apps Market Size, Share & Trends Analysis Report By Platform (iOS, Android), By Device (Smartphones, Tablets, Wearables), By Indication (Obesity, Cardiovascular Health), By Region, And Segment Forecasts, 2024 - 2030
... Market Growth & Trends The global lifestyle diseases apps market size is expected to reach USD 13.77 billion by 2030, registering a CAGR of 15.0% from 2024 to 2030, according to a new report by ... Read More
-
Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2024-2032
... US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.8 Billion by 2032, exhibiting a growth rate (CAGR) of 17.5% during 2024-2032. The growing demand for digital behavior-monitoring treatment, ... Read More
-
Bariatric Surgery Devices Market Report by Procedure Type (Minimally Invasive Surgical Procedures, Non-Invasive Surgical Procedures), Device Type (Assisting Devices, Implantable Devices), Procedure (Sleeve Gastrectomy, Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch, and Others), Application (Weight Loss, Hereditary Disease, and Other Disorders), End-User (Bariatric Surgery Clinics, Hospitals, and Others), and Region 2024-2032
... and Others), Application (Weight Loss, Hereditary Disease, and Other Disorders), End-User (Bariatric Surgery Clinics, Hospitals, and Others), and Region 2024-2032 The global bariatric surgery devices market size reached US$ 2.9 Billion in 2023. Looking forward, ... Read More
-
Global Bariatric Surgical Devices Market 2024-2028
... forecast period. The report on the bariatric surgical devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Trocar Market Size Study, by Product (Accessories, Disposable Trocar, Reposable Trocar, Reusable Trocar), by Tip (Bladed Trocar, Bladeless Trocar, Blunt Trocar, Optical Trocar), by Application (Bariatric Surgery, General Surgery, Gynecological Surgery, Urological Surgery), by End User (Ambulatory Surgical Center, Hospital), and Regional Forecasts 2022-2032
... End User (Ambulatory Surgical Center, Hospital), and Regional Forecasts 2022-2032 Global Trocar Market is valued at approximately USD 762.50 million in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
GLP-1 Analogues Market by Product (Ozempic, Rybelsus, Saxenda, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity), Format (Single dose, Multi-dose, Tablets), ROA (Subcutaneous, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2032
... to reach USD 471.1 billion by 2032 from USD 47.4 billion in 2024, at a CAGR of 33.2% during the forecast period. The key factors driving the growth of the GLP-1 Analogues market include the ... Read More
-
Global Anorexiants Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Body Composition Analyzers
... by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. Bio-Impedance Analyzers, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$471.4 Million by ... Read More
-
Bariatric (Obesity) Surgical Devices
... reach US$5.5 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach ... Read More
-
Global Endothelial Dysfunction Market: Analysis By Test Type (Invasive Tests and Non-Invasive Tests), By Cause (Hypertension, Diabetes, Hypercholestrolaemia, Behcet’s Disease, Obesity, and Others), By End-User (Hospitals, Diagnostics Centers, Clinics, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count 163 Units Referenced US $ Segments/Key Topics By ... Read More
-
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024–2028
... obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 ... Read More
-
Body Composition Analyzers Market Size, Share & Trends by Products (Bioimpedance analyzers, DEXA, Skinfold Calipers, ADP), Modality (Portable, Stationary), Application (Segmental, Whole Body Measurement), Distribution Channel (E-commerce, Offline) - Global Forecasts to 2029
... composition analyzers market is valued at an estimated USD 0.8 billion in 2024 and is projected to reach USD 1.2 billion by 2029 at a CAGR of 9.3% during the forecast period. Body composition analyzers ... Read More
Research Assistance
